• Home
  • Search Results

Search Results

2532 studies match your search
By physician referral or invitation only

Antibacterial resistance in people living with HIV

To learn more about multidrug-resistant bacteria in persons living with HIV.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • HIV/AIDS
  • Immune System/Infections
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Perceptions of microbiome engineering technologies among hospital nurses

Healthcare acquired infections (HAIs) contribute substantially to the burden of morbidity and mortality among hospitalized patients in the United States and are a significant economic burden on the healthcare system. Approximately 3-5% of patients in the United States contract a HAI during the course of their treatment, and an estimated $7-14 billion are spent annually on treating these infections. HAIs also contribute to development of antimicrobial resistance (AMR), placing additional burden on the healthcare system and substantially raising the costs of treatment. Novel microbiome engineering technologies that address the HAI problem are currently being developed by researchers. We will conduct a qualitative study to assess the factors influencing the adoption of novel microbiome engineering among hospital nurses in the United States.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Researchers Views on Human Gene Editing

We will interview researchers whose work involves the science of gene editing or policy implications of human gene editing. We will also conduct observations at conferences and other public meetings. The interviews and observations will document researchers' perspectives on the scientific prospects for applying human gene editing to the prevention of disease, enhancement concerns that might be generated, and views on the appropriate governance of human genome editing research.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Genetics and Genetic Disorders
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

The Development of Novel Patient Reported Outcomes for Evaluating Quality of Life in Patients who have had a Colectomy for Ulcerative Colitis

To develop novel PROs for evaluating QoL among patients after IPAA, including those with acute pouchitis and chronic pouch-related conditions.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Stomach, Digestion and Gut Health
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Study of early-stage squamous cell carcinoma skin cancer injected with medication

The goal of this study is to see how well a medication called Cemiplimab works when it's injected directly into a skin cancer, instead of using surgery.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Skin, Hair, and Nails
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

MK-8527 as HIV-1 PrEP

To test the safety of the trial drug, MK-8527 compared to emtricitabine/tenofovir (FTC/TDF) and to see how well MK-8527 works to reduce the chance of getting HIV-1 infection compared to FTC/TDF.

Age & Gender
  • 16 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
  • HIV/AIDS
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Durham place study

This study aims to understand how the cities of Durham and of Chapel Hill have changed over time. It seeks to engage neighborhood level change and gain insight into placemaking and engagement with planning processes on a local level.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Environment
Visit Location
100% Remote (online, phone, text)

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation

The main purpose of this study is to determine how much MRTX849 can safely be administered to people. This will include looking at what side effects occur and how often they occur.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Phase 1 Trials (all cancers))
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

10-CBA: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications. This protocol will allow access to cord blood units that are unlicensed.

Age & Gender
  • 1 months ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Chronic Conditions
  • Transplant
  • and 2 more
Visit Location
100% Remote (online, phone, text)
By physician referral or invitation only

Impacts of Extreme Events

Hurricanes and other extreme storms often cause damage in North Carolina. This study collects data from communities and households to understand the short and long term impacts of these events and how individuals, families, and communities respond to and recover from them. The data will help us assess the full costs of extreme events and what families need in their aftermath.

Age & Gender
  • 15 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
  • Mental and Emotional Health
Visit Location
100% Remote (online, phone, text)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research